होम › मल्टीपल मायलोमा › इलिनॉय › Chicago
Chicago, IL में मल्टीपल मायलोमा क्लिनिकल ट्रायल
Chicago (लगभग 30 मील के भीतर) की साइटों पर मल्टीपल मायलोमा के लिए 22 अध्ययन प्रतिभागियों की तलाश में हैं। यह देखने के लिए कि कौन शामिल हो सकता है और अध्ययन टीम से कैसे संपर्क करें, एक अध्ययन खोलें।
आधिकारिक अध्ययन पाठ (अंग्रेजी)
यहाँ अध्ययन के लिए भर्ती कर रहे हैं? इसे इस पृष्ठ के शीर्ष पर फीचर करें — 30 दिनों के लिए $99 →
A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
भर्ती जारीचरण 1
- University of Chicago Medical Center /ID# 278863, Chicago
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
भर्ती जारीचरण 3
- Research Site, Chicago
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
भर्ती जारीचरण 1/2
- University of Chicago Medical Center, Chicago
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
भर्ती जारीचरण 3
- Rush University System for Health, Chicago
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
भर्ती जारीचरण 3
- University Of Illinois Medical Center, Chicago
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
भर्ती जारीचरण 4
- Northwestern University, Chicago
- University of Chicago, Chicago
Study of Belantamab Mafodotin With Carfilzomib, Pomalidomide, and Dexamethasone in Relapsed Multiple Myeloma
भर्ती जारीचरण 2
- University of Chicago Medicine Comprehensive Cancer Center, Chicago
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
भर्ती जारीचरण 2
- Cancer Treatment Centers of America-Chicago, Chicago
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
भर्ती जारीचरण 2
- Northwestern Memorial Hospital, Chicago
- University of Chicago Medical Center, Chicago
Post-Autologous Transplant Maintenance With Isatuximab and Lenalidomide in Minimal Residual Disease Positive Multiple Myeloma
भर्ती जारीचरण 2
- University of Illinois at Chicago, Chicago
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
भर्ती जारीचरण 3
- Endeavor Health - Swedish Hospital, Chicago
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
भर्ती जारीचरण 3
- Advocate Illinois Masonic Medical Center, Chicago
AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
भर्ती जारीचरण 1/2
- Research Site, Chicago
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
भर्ती जारीचरण 3
- Research Site, Chicago
Mosaic Trial for Stem Cell Transplant Recipients
भर्ती जारी
- Northwestern University Feinberg School of Medicine, Chicago
Personalized Autologous Transplant for Multiple Myeloma
भर्ती जारीचरण 1
- University Illinois Chicago, Chicago
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
भर्ती जारीचरण 3
- University of Chicago, Chicago
- University of Illinois Medical Center at Chicago, Chicago
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
भर्ती जारीचरण 1
- University of Chicago, Chicago
Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)
भर्ती जारीचरण 1
- University of Chicago Medical Center, Chicago
Hypofractionation (Radiation) Trial for Multiple Myeloma
भर्ती जारीचरण 1
- The University of Chicago Comprehensive Cancer Center, Chicago
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
भर्ती जारीचरण 1/2
- Northwestern, Chicago
Free From Maintenance Drug Therapy in Multiple Myeloma (The FREEDMM Trial) for Minimal Residual Disease (MRD
भर्ती जारीचरण 1
- University of Illinois Cancer Center, Chicago
अन्य शहरों में मल्टीपल मायलोमा ट्रायल
- New York City, NY60 अध्ययन
- Boston, MA42 अध्ययन
- Atlanta, GA41 अध्ययन
- Houston, TX38 अध्ययन
- Durham, NC37 अध्ययन
- Nashville, TN32 अध्ययन
- Denver, CO27 अध्ययन
- Rochester, MN24 अध्ययन
- St. Louis, MO24 अध्ययन
- Columbus, OH24 अध्ययन
- Baldwin Park, CA23 अध्ययन
- Seattle, WA22 अध्ययन
Chicago में अन्य अध्ययन
- नॉन-स्मॉल सेल लंग कैंसर61 अध्ययन
- स्तन कैंसर58 अध्ययन
- कैंसर (सभी प्रकार)51 अध्ययन
- मेटास्टेटिक कैंसर45 अध्ययन
- प्रोस्टेट कैंसर45 अध्ययन
- मोटापा41 अध्ययन
- फेफड़ों का कैंसर41 अध्ययन
- अंडाशय का कैंसर36 अध्ययन
- स्ट्रोक34 अध्ययन
- कोलोरैक्टल कैंसर33 अध्ययन
- हृदय अस्वस्थता31 अध्ययन
- अधिक वजन28 अध्ययन
ClinicalTrials.gov से, 5 अक्तू॰ 2026 को प्राप्त डेटा। प्रत्येक अध्ययन अपनी योग्यता निर्धारित करता है; अध्ययन टीम तय करती है कि कौन शामिल हो सकता है।